approval · primary record
MINOCYCLINE HYDROCHLORIDE
4 approval events · latest 2026-01-29
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-01-29 |
| Approval events | 4 |
| Brand | XIMINO |
| Sponsor | JOURNEY |
| Route | ORAL |
Approval history
4 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-01-29 | FDA | NDA | XIMINO | JOURNEY | ORAL |
| 2025-04-01 | FDA | NDA | SOLODYN | BAUSCH | ORAL |
| 2025-03-31 | FDA | NDA | MINOCIN | BAUSCH | ORAL |
| 2024-11-01 | FDA | NDA | EMROSI | JOURNEY | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:32:14.281Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:minocycline-hydrochloride
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Minocycline Hydrochloride · compound